Saturday, February 26, 2022

Beat Inflation, Dominate 2022

Unsubscribe

Hey Trader,

Time is running short for our special Live A.I. Training – your opening to dominate 2022 and make it your best trading year yet!

Beating inflation and picking great trades has never been easier with machine learning on your side. By putting processes in place for how to utilize your capital wisely, you can build a stronger portfolio than ever before.

As you might've heard, there is overwhelming evidence suggesting that artificial intelligence is poised to take trading stocks, Futures, ETFs, Forex, and crypto to the next level.

Why?

Because A.I. forecasts market trends up to 72 hours in advance, with up to 87.4% accuracy. So you have plenty of time to get in and get out of any trade.

Here is what a few members of our community of over 35,000 traders are saying:

·         Alison M. says, "VantagePoint is also a tool that lessens the uncertainity to my capital and helps preserve what I've got."

·         Norberto T. says, "VantagePoint has given me the opening to cherry pick the best trades available. I highly recommend this software for people who are looking for about their trading triumph."

·         Mark D. says, "Now that I have VantagePoint, my other technical trading indicators have suddenly become obsolete."

If you're interested in seeing our A.I. software for free, just lock in your registration to our Live Training here before it expires at the end of the day.

Please remember to bring some ticker symbols for us to demonstrate on the software.

Happy Trading!

Lane Mendelsohn

President, Vantagepoint AI
1-800-732-5407 U.S. & Canada 
1-813-973-0496 International

 

Please note examples are from past data and are triumph stories. Trading involves financial uncertainity and is not suitable for all investors. Past results do not guarantee future performance.


DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that StockEarnings Inc. "StockEarnings's" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. StockEarnings's has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment.

Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at http: //www.sec .gov and the Financial Industry Regulatory Authority (the "FINRA") at http: //www. FINRA .org. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at http: //www.sec .gov/consumer as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence.

You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company.

Unsubscribe

StockEarnings
110, Wall Street, Floor 3, New York, NY 10005
W: 877.6.STOCKS

StockEarnings.com

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...